Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lotus BioScience Ventures was a Hong Kong-based venture capital firm that specialized in early- to mid-stage investments within the biotechnology and life sciences sectors. Active primarily during the early to mid-2000s, the firm was a notable participant in significant funding rounds for several innovative biopharmaceutical companies, including KaloBios Pharmaceuticals, Nereus Pharmaceuticals, and Signature BioScience. The firm focused on identifying and supporting companies developing novel therapeutic platforms and drug discovery technologies. Although the firm is no longer active, it played a significant role in the venture ecosystem for biotherapeutics during its operational period.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lotus BioScience Ventures.